TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32510144

Group type: EXPERIMENTAL
Intervention: Blood Orange Juice (BOJ)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control Drink (CD)
Number of subjects: 15
Study: 35394387

Group type: EXPERIMENTAL
Intervention: Peritoneal Dialysis (PD)
Number of subjects: 1082

Group type: COMPARATOR
Intervention: Conventional in-centre Haemodialysis (HD)
Number of subjects: 1082
Study: 34605384

Group type: EXPERIMENTAL
Intervention: Peer support group (PSG)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Dietician-led support group (DSG)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Minimal support group (MSG)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: All groups combined
Number of subjects: 75
Study: 36008059

Group type: EXPERIMENTAL
Intervention: Sudarshan Kriya Yoga (SKY)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Cognitive Processing Therapy (CPT)
Number of subjects: 85
Study: 33275764

Group type: EXPERIMENTAL
Intervention: Inoculation with Pst
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: CSEP Unigene17495 (PSTG 10917)
Number of subjects: 2
Study: 32566685

Group type: EXPERIMENTAL
Intervention: Exenatide
Number of subjects: 95

Group type: COMPARATOR
Intervention: Humalog Mix25
Number of subjects: 95
Study: 36252683

Group type: EXPERIMENTAL
Intervention: Exergaming (EXE)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Conventional therapy (CON)
Number of subjects: 22
Study: 32880201

Group type: EXPERIMENTAL
Intervention: Royal Jelly (RJ) supplementation (3000 mg of fresh RJ equivalent)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 32833495

Group type: EXPERIMENTAL
Intervention: Drain placement during surgery
Number of subjects: 148260

Group type: COMPARATOR
Intervention: No drain placement during surgery
Number of subjects: 148260
Study: 35932444

Group type: EXPERIMENTAL
Intervention: Empirical additional ablation (EAA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (limited single point ablation)
Number of subjects: 0
Study: 32074648

Group type: EXPERIMENTAL
Intervention: Combined use of naphthalan applications and non-selective Bioptron chromotherapy
Number of subjects: 64

Group type: COMPARATOR
Intervention: Isolated effect of naphthalan
Number of subjects: 64
Study: 33906810

Group type: EXPERIMENTAL
Intervention: MR‐proADM guided arm (low MR‐proADM value ≤0.87 nmol/L)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: MR‐proADM guided arm (high MR‐proADM value >0.87 nmol/L)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: MR‐proADM guided arm (per protocol population)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control arm (Standard Care)
Number of subjects: 200
Study: 32128844

Group type: COMPARATOR
Intervention: Trimetazidine (TMZ) in healthy elderly (55-65 years, 66-75 years, >75 years) dosed B.D. for 4 days
Number of subjects: 73

Group type: COMPARATOR
Intervention: Trimetazidine (TMZ) in healthy elderly (>75 years) dosed B.D. for 4 days
Number of subjects: 73

Group type: COMPARATOR
Intervention: Trimetazidine (TMZ) in mild renal impairment dosed B.D. for 8 days
Number of subjects: 73

Group type: COMPARATOR
Intervention: Trimetazidine (TMZ) in moderate renal impairment dosed O.D. for 8 days
Number of subjects: 73

Group type: COMPARATOR
Intervention: Trimetazidine (TMZ) in severe renal impairment (no dialysis) dosed once every 48h for 8 days
Number of subjects: 73
Study: 34215144

Group type: EXPERIMENTAL
Intervention: Deep Transcranial Magnetic Stimulation (dTMS) to the right prefrontal cortex (rPFC)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Deep Transcranial Magnetic Stimulation (dTMS) to the left prefrontal cortex (lPFC)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Sham stimulation (control group)
Number of subjects: 62
Study: 36434823

Group type: EXPERIMENTAL
Intervention: Pneumoperitoneum pressure of 15 mmHg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Pneumoperitoneum pressure of 12 mmHg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Pneumoperitoneum pressure of 10 mmHg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Pneumoperitoneum pressures (12 mmHg and 10 mmHg)
Number of subjects: 40
Study: 34416193

Group type: EXPERIMENTAL
Intervention: ChAdOx1 nCoV-19 vaccine (two doses, 28 days apart)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: ChAdOx1 nCoV-19 vaccine
Number of subjects: 174
Study: 32408925

Group type: EXPERIMENTAL
Intervention: Food insecurity prevalence
Number of subjects: 212608

Group type: EXPERIMENTAL
Intervention: Odds of food insecurity
Number of subjects: 212608

Group type: EXPERIMENTAL
Intervention: Association with sociodemographic factors
Number of subjects: 212608

Group type: EXPERIMENTAL
Intervention: Income, smoking status, and self-rated health
Number of subjects: 212608

Group type: EXPERIMENTAL
Intervention: Age-related increase in food insecurity
Number of subjects: 212608
Study: 35964021

Group type: EXPERIMENTAL
Intervention: Minimalist flexible footwear (MFG)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Customized insole on footwear (COIG)
Number of subjects: 43
Study: 34192666

Group type: EXPERIMENTAL
Intervention: Open science dataset from PREVENT-AD cohort
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: Longitudinal imaging data
Number of subjects: 386

Group type: EXPERIMENTAL
Intervention: Sensitive information
Number of subjects: 386
Study: 32969200

Group type: EXPERIMENTAL
Intervention: Probiotic group (n=12) received mesalazine (60 mg kg−1 day−1) and oral probiotics (Lactobacillus casei Zhang, Lactobacillus plantarum P‐8, Bifidobacterium animalis subsp. lactis V9) twice daily for 12 weeks
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo group (n=13) received the same amounts of mesalazine and placebo
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Probiotic group
Number of subjects: 25
Study: 36265219

Group type: EXPERIMENTAL
Intervention: Aerobic cycling intervention (PDex, N = 14)
Number of subjects: 28

Group type: COMPARATOR
Intervention: No intervention control group (PDcontrol, N = 14)
Number of subjects: 28
Study: 33296553

Group type: EXPERIMENTAL
Intervention: Low-intensity pulsed ultrasound (LIPUS) administered twice weekly for 24 weeks
Number of subjects: 27

Group type: COMPARATOR
Intervention: Sham sonification
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Low-intensity pulsed ultrasound (LIPUS)
Number of subjects: 27
Study: 36374656

Group type: EXPERIMENTAL
Intervention: Office-GAP + mHealth
Number of subjects: 51

Group type: COMPARATOR
Intervention: mHealth only
Number of subjects: 51
Study: 35892316

Group type: EXPERIMENTAL
Intervention: Atrasentan (dosage not specified)
Number of subjects: 3329
Study: 34010324

Group type: EXPERIMENTAL
Intervention: 0.9% saline
Number of subjects: 1060

Group type: COMPARATOR
Intervention: Plasma-Lyte 148
Number of subjects: 1060
Study: 32414901

Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study: 36070308

Group type: EXPERIMENTAL
Intervention: Brief mindfulness training (MT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Active control
Number of subjects: 40
Study: 32466858

Group type: EXPERIMENTAL
Intervention: Senofilcon A lenses with polyquaternium-based care solution (OPTI-FREE Replenish)
Number of subjects: 0
Study: 32006156

Group type: EXPERIMENTAL
Intervention: 23-month ticagrelor monotherapy following 1-month dual antiplatelet therapy (DAPT)
Number of subjects: 15968

Group type: COMPARATOR
Intervention: 12-month aspirin monotherapy following 12-month DAPT
Number of subjects: 15968
Study: 35267097

Group type: EXPERIMENTAL
Intervention: 1.4 ml 2% lidocaine + 0.4 ml (40 μg) dexmedetomidine (DEX)
Number of subjects: 50

Group type: COMPARATOR
Intervention: 1.4 ml 2% plain lidocaine
Number of subjects: 50
Study: 33208091

Group type: EXPERIMENTAL
Intervention: Preoperative anxiety measured using the Amsterdam Preoperative Anxiety and Information Scale and the Visual Analogue Scale for anxiety
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Postoperative delirium measured using the Confusion Assessment Method for ICU and the 3 Minute Diagnostic Interview for Confusion Assessment Method
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Activities of daily living
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Diabetes mellitus
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Time on cardiopulmonary bypass
Number of subjects: 190
Study: 35350100

Group type: EXPERIMENTAL
Intervention: Probiotics
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 34429952

Group type: EXPERIMENTAL
Intervention: Topical application of tranexamic acid (TXA) 500mg/5 mL, total 10 mL at the surgical site.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no TXA applied).
Number of subjects: 40
Study: 35900820

Group type: EXPERIMENTAL
Intervention: Digital health education intervention (animated health videos and access to InfoSpots)
Number of subjects: 600

Group type: EXPERIMENTAL
Intervention: Use of InfoSpots
Number of subjects: 600
Study: 33381577

Group type: EXPERIMENTAL
Intervention: 3DGT-UKA
Number of subjects: 22

Group type: COMPARATOR
Intervention: T-UKA
Number of subjects: 22
Study: 33541343

Group type: EXPERIMENTAL
Intervention: Rapid Ethical Assessment (REA)
Number of subjects: 0
Study: 34710071

Group type: EXPERIMENTAL
Intervention: Pericoital tenofovir 1% gel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 0
Study: 33073954

Group type: EXPERIMENTAL
Intervention: Accu-Chek
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: OneTouch
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Freestyle Optium Neo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Contour Next One
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Contour Next
Number of subjects: 0
Study: 34480579

Group type: EXPERIMENTAL
Intervention: Daridorexant 50 mg
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Daridorexant 100 mg
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Daridorexant 150 mg
Number of subjects: 63

Group type: COMPARATOR
Intervention: Suvorexant 150 mg
Number of subjects: 63

Group type: COMPARATOR
Intervention: Zolpidem 30 mg
Number of subjects: 63

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study: 34547081

Group type: EXPERIMENTAL
Intervention: Slower infusion rate (333 mL/h)
Number of subjects: 11052

Group type: COMPARATOR
Intervention: Control infusion rate (999 mL/h)
Number of subjects: 11052
Study: 32989082

Group type: EXPERIMENTAL
Intervention: 5As-based clinician-delivered smoking cessation counseling intervention
Number of subjects: 120

Group type: COMPARATOR
Intervention: Social media counseling (attentional control)
Number of subjects: 120
Study: 33750627

Group type: EXPERIMENTAL
Intervention: Machine-generated whole body vibration
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Self-generated whole body vibration
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo vocal resting group (voice rest)
Number of subjects: 24
Study: 34419868

Group type: EXPERIMENTAL
Intervention: Cognitive-physical dual-task training based on fairy tales (60-90 min once a week for 12 weeks)
Number of subjects: 9
Study: 32715513

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT) intervention, 8-week group-delivered
Number of subjects: 65
Study: 34041527

Group type: EXPERIMENTAL
Intervention: Headgear activator treatment in mixed dentition (MD) starting at age 9
Number of subjects: 56

Group type: COMPARATOR
Intervention: Headgear activator treatment in late mixed dentition (LMD) starting at age 11
Number of subjects: 56
Study: 32811168

Group type: EXPERIMENTAL
Intervention: XEN 63 Gel Stent
Number of subjects: 11
Study: 32993799

Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 33485062

Group type: EXPERIMENTAL
Intervention: Approximately 3000 randomly selected SNPs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Next generation sequencing experiment
Number of subjects: 0
Study: 34419109

Group type: EXPERIMENTAL
Intervention: Simethicone solution intake 31‐60 minutes before procedure (group 2)
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Simethicone solution intake 20‐30 minutes before procedure (group 1)
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Simethicone solution intake > 60 minutes before procedure (group 3)
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Satisfaction scores immediately after examination
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Satisfaction scores 2 hours after examination
Number of subjects: 302
Study: 32216909

Group type: EXPERIMENTAL
Intervention: Alteplase 10 mg
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: Alteplase 20 mg
Number of subjects: 440

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 440
Study: 36038370

Group type: EXPERIMENTAL
Intervention: Total extraperitoneal
Number of subjects: 243

Group type: COMPARATOR
Intervention: Lichtenstein
Number of subjects: 243
Study: 32863148

Group type: EXPERIMENTAL
Intervention: Professional flash glucose monitoring
Number of subjects: 288

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 288
Study: 32468987

Group type: EXPERIMENTAL
Intervention: Food-related ads
Number of subjects: 7991

Group type: EXPERIMENTAL
Intervention: Ultra-processed food ads
Number of subjects: 7991
Study: 35594075

Group type: EXPERIMENTAL
Intervention: Full panretinal photocoagulation
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab (IVB) with four monthly injections
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: Modified combination group with two bimonthly IVB injections and modified laser therapy
Number of subjects: 207
Study: 34708929

Group type: EXPERIMENTAL
Intervention: Task-shared, nurse-delivered cognitive-behavioral therapy for adherence and depression (CBT-AD)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Enhanced treatment as usual (ETAU)
Number of subjects: 161
Study: 35304120

Group type: EXPERIMENTAL
Intervention: AphasiaScripts (computer-based script training program) with high complexity
Number of subjects: 16

Group type: COMPARATOR
Intervention: AphasiaScripts (computer-based script training program) with low complexity
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: AphasiaScripts with high feedback
Number of subjects: 16

Group type: COMPARATOR
Intervention: AphasiaScripts with low feedback
Number of subjects: 16
Study: 32196976

Group type: EXPERIMENTAL
Intervention: Tafamidis 61-mg free acid capsules
Number of subjects: 30

Group type: COMPARATOR
Intervention: Tafamidis meglumine 80-mg (4 × 20-mg) capsules
Number of subjects: 30
Study: 32473644

Group type: EXPERIMENTAL
Intervention: Cardiac Shockwave Therapy (SWT) during CABG surgery
Number of subjects: 80

Group type: COMPARATOR
Intervention: CABG surgery with sham treatment
Number of subjects: 80
Study: 35023346

Group type: EXPERIMENTAL
Intervention: Nurse-facilitated educational intervention for 3 months
Number of subjects: 402
Study: 34143970

Group type: EXPERIMENTAL
Intervention: Avelumab plus pegylated liposomal doxorubicin (PLD) (40 mg/m2 intravenously every 4 weeks)
Number of subjects: 566

Group type: EXPERIMENTAL
Intervention: Avelumab (10 mg/kg intravenously every 2 weeks)
Number of subjects: 566

Group type: COMPARATOR
Intervention: Pegylated liposomal doxorubicin (PLD) alone
Number of subjects: 566
Study: 32051303

Group type: EXPERIMENTAL
Intervention: Melatonin (four doses of 10 mg each)
Number of subjects: 722

Group type: COMPARATOR
Intervention: Placebo (same dosing regime as melatonin)
Number of subjects: 722

Group type: EXPERIMENTAL
Intervention: Melatonin
Number of subjects: 722
Study: 35388276

Group type: EXPERIMENTAL
Intervention: Clomiphene/Sildenafil (C/S)
Number of subjects: 595

Group type: COMPARATOR
Intervention: Clomiphene citrate (CC)
Number of subjects: 595
Study: 34981479

Group type: EXPERIMENTAL
Intervention: Curcumin capsules with piperine supplement (500 mg/day, 95% curcuminoids) for 8 weeks
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 72
Study: 36181455

Group type: EXPERIMENTAL
Intervention: High arousal stimuli
Number of subjects: 271

Group type: EXPERIMENTAL
Intervention: Low arousal stimuli
Number of subjects: 271

Group type: COMPARATOR
Intervention: Neutral word presented with high arousal word
Number of subjects: 271
Study: 34583760

Group type: EXPERIMENTAL
Intervention: Monofilament suture
Number of subjects: 2050

Group type: COMPARATOR
Intervention: Braided suture
Number of subjects: 2050
Study: 32383985

Group type: EXPERIMENTAL
Intervention: Quetiapine augmentation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aripiprazole augmentation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 35704960

Group type: EXPERIMENTAL
Intervention: Food supplement containing standardized menthol, limonene, and gingerol, administered for 30 days in addition to standard treatment.
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo, administered for 30 days in addition to standard treatment.
Number of subjects: 56
Study: 34256715

Group type: EXPERIMENTAL
Intervention: Internet delivered Cognitive Behavior Therapy with exposure (ICBT)
Number of subjects: 309

Group type: COMPARATOR
Intervention: Internet delivered Cognitive Behavior Therapy without exposure (ICBT-WE)
Number of subjects: 309

Group type: EXPERIMENTAL
Intervention: ICBT
Number of subjects: 309
Study: 32217746

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 33257279

Group type: EXPERIMENTAL
Intervention: Dipyrone 25 mg kg−1 every 24 hours
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Dipyrone 12.5 mg kg−1 every 12 hours
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Meloxicam 0.1 mg kg−1 every 24 hours
Number of subjects: 30

Group type: COMPARATOR
Intervention: Rescue analgesia (tramadol, 2 mg kg−1 IV)
Number of subjects: 30
Study: 35803512

Group type: EXPERIMENTAL
Intervention: Operative analgesic treatments with pharmacologic analgesia (OP) group, n = 30
Number of subjects: 59

Group type: COMPARATOR
Intervention: Pharmacologic analgesia (P) group, n = 29
Number of subjects: 59
Study: 33239135

Group type: EXPERIMENTAL
Intervention: Ginsenoside treatment
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 80
Study: 36775530

Group type: EXPERIMENTAL
Intervention: Pilates group (n = 16)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (n = 18)
Number of subjects: 34
Study: 33991178

Group type: EXPERIMENTAL
Intervention: Sodium-glucose co-transporter-2 inhibitors (SGLT2i)
Number of subjects: 515
Study: 34147692

Group type: COMPARATOR
Intervention: 0 units of pituitrin
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: 2 units of pituitrin
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: 4 units of pituitrin
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: 6 units of pituitrin
Number of subjects: 118
Study: 33044441

Group type: EXPERIMENTAL
Intervention: Resistance Exercise (RE)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (rest)
Number of subjects: 10
Study: 32531428

Group type: EXPERIMENTAL
Intervention: 0.8 ng/kg lipopolysaccharide (LPS) as inflammatory stimulus
Number of subjects: 40

Group type: COMPARATOR
Intervention: Physiological saline as placebo
Number of subjects: 40
Study: 35377518

Group type: EXPERIMENTAL
Intervention: Onabotulinum toxin injections (12 units, 1:2.5)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Onabotulinum toxin injections (6 units, 1:5)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Onabotulinum toxin injections (4 units, 1:7.5)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 0.9% normal saline injection
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 15
Study: 34215615

Group type: EXPERIMENTAL
Intervention: Health Coaching (HC)
Number of subjects: 800

Group type: COMPARATOR
Intervention: Control (non-HC treatment)
Number of subjects: 800
Study: 32956891

Group type: EXPERIMENTAL
Intervention: Novel shiny model for predicting survival
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Training sample analysis
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Validation sample analysis
Number of subjects: 265
Study: 36003008

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33980691

Group type: EXPERIMENTAL
Intervention: Adiposity-increasing alleles (UFA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adiposity-decreasing alleles (FA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: UFA
Number of subjects: 0

Group type: COMPARATOR
Intervention: FA
Number of subjects: 0
Study: 33202219

Group type: EXPERIMENTAL
Intervention: Ticagrelor (180 mg loading dose, 90 mg twice daily for 30 days)
Number of subjects: 1910

Group type: COMPARATOR
Intervention: Clopidogrel (300–600 mg loading dose, 75 mg daily for 30 days)
Number of subjects: 1910

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 1910

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 1910
Study: 36189651

Group type: EXPERIMENTAL
Intervention: Polynucleotides and hyaluronic acid based gel
Number of subjects: 50
Study: 33356408

Group type: EXPERIMENTAL
Intervention: Updated Nutrition Facts label (single column)
Number of subjects: 992

Group type: EXPERIMENTAL
Intervention: Updated Nutrition Facts label (dual column)
Number of subjects: 992

Group type: COMPARATOR
Intervention: Original Nutrition Facts label
Number of subjects: 992
Study: 32565458

Group type: EXPERIMENTAL
Intervention: Oral ibuprofen + oral hydromorphone
Number of subjects: 536

Group type: EXPERIMENTAL
Intervention: Oral ibuprofen + oral acetaminophen
Number of subjects: 536

Group type: COMPARATOR
Intervention: Oral ibuprofen alone
Number of subjects: 536
Study: 35328964

Group type: EXPERIMENTAL
Intervention: Inertial training (twice per week for 6 weeks, training load of about 70% of maximal force)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Inertial training
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Inertial training and Control group
Number of subjects: 24
Study: 33974370

Group type: EXPERIMENTAL
Intervention: Isotonic ophthalmic solution of 0.5% ozonised oil in liposomes plus hypromellose treatment (2 drops 4 times/day)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Saline solution
Number of subjects: 174
Study: 32525413

Group type: EXPERIMENTAL
Intervention: 12-month home-based exercise program
Number of subjects: 98

Group type: COMPARATOR
Intervention: Usual care group (one guidance session for light home-exercises)
Number of subjects: 98